China
· Delayed Price · Currency is CNY Wuhan Easy Diagnosis Biomedicine Company Description
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic products China and internationally.
Its products portfolio includes molecular diagnostic products, such as PCR system, nucleic acid extraction and purification instrument, and sample release reagent; blood gas analyzer; immuno diagnosis, including chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer; and automatic coagulation analyzer.
The company also provides emergency and critical illness information solutions, including software, hardware, and certification consulting services; and third-party medical inspection services.
It offers products in the areas of cardiovascular and cerebrovascular diseases, infectious diseases, kidney diseases, diabetes, infectious diseases, prenatal and postnatal care, health examination, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection, etc. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.
| Country | China |
| Founded | 2008 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,063 |
| CEO | Chen Li Li |
Contact Details
Address: East Lake Hi-Tech Development Zone Wuhan, 430074 China | |
| Phone | 86 27 6552 3649 |
| Website | mdeasydiagnosis.com |
Stock Details
| Ticker Symbol | 002932 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000033Q7 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Chen Li Li | Chairman and GM |
| Wang Ying | Vice Chairman and Deputy GM |
| Rui Wang | Deputy GM, Chief Financial Officer and Board Secretary |